MENU
FBT
ETF ticker: NYSE ARCA
PRICE
CHANGE
NET ASSETS

FBT stock forecast, quote, news & analysis

The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of an equity index called the NYSE ® Arca ® Biotechnology Index... Show more

Category: #Health
A.I.Advisor
published price charts
A.I.Advisor
a Summary for FBT with price predictions
Nov 10, 2026

FBT in upward trend: price rose above 50-day moving average on November 09, 2026

FBT moved above its 50-day moving average on November 09, 2026 date and that indicates a change from a downward trend to an upward trend. In 33 of 37 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 89%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 48 of 59 cases where FBT's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 81%.

The 10-day moving average for FBT crossed bullishly above the 50-day moving average on October 27, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 13 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 81%.

Following a +3.06% 3-day Advance, the price is estimated to grow further. Considering data from situations where FBT advanced for three days, in 296 of 341 cases, the price rose further within the following month. The odds of a continued upward trend are 87%.

The Aroon Indicator entered an Uptrend today. In 252 of 283 cases where FBT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 89%.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on FBT as a result. In 68 of 91 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 75%.

The Moving Average Convergence Divergence Histogram (MACD) for FBT turned negative on November 05, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 52 similar instances when the indicator turned negative. In 38 of the 52 cases the stock turned lower in the days that followed. This puts the odds of success at 73%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where FBT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 79%.

FBT broke above its upper Bollinger Band on October 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Amgen (NASDAQ:AMGN), Gilead Sciences (NASDAQ:GILD), Regeneron Pharmaceuticals (NASDAQ:REGN), Biogen (NASDAQ:BIIB), Illumina (NASDAQ:ILMN), Incyte Corp (NASDAQ:INCY), Exelixis (NASDAQ:EXEL).

Industry description

The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of an equity index called the NYSE ® Arca ® Biotechnology Index. The fund will normally invest at least 90% of its net assets (including investment borrowings) in the securities that comprise the index. The index is an equal-dollar weighted index designed to measure the performance of 30 leading biotechnology companies.

Market Cap

The average market capitalization across the First Trust NYSE Arca Biotechnology Index Fund (FBT) ETF is 39.53B. The market cap for tickers in the group ranges from 1.94B to 248.92B. AMGN holds the highest valuation in this group at 248.92B. The lowest valued company is VCYT at 1.94B.

High and low price notable news

The average weekly price growth across all stocks in the First Trust NYSE Arca Biotechnology Index Fund (FBT) ETF was -2%. For the same ETF, the average monthly price growth was 2%, and the average quarterly price growth was 28%. ONC experienced the highest price growth at 19%, while VCYT experienced the biggest fall at -52%.

Volume

The average weekly volume growth across all stocks in the First Trust NYSE Arca Biotechnology Index Fund (FBT) ETF was -16%. For the same stocks of the ETF, the average monthly volume growth was -7% and the average quarterly volume growth was -32%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 71
P/E Growth Rating: 47
Price Growth Rating: 42
SMR Rating: 60
Profit Risk Rating: 58
Seasonality Score: 20 (-100 ... +100)
FBT in upward trend: price rose above 50-day moving average on November 09, 2026